IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,596,110 | -40.5% | 2,719,592 | -2.1% | 0.00% | – |
| Q2 2023 | $7,720,716 | +60.1% | 2,777,236 | +4.8% | 0.00% | – |
| Q1 2023 | $4,822,660 | -92.9% | 2,649,813 | -80.3% | 0.00% | -100.0% |
| Q4 2022 | $68,303,558 | +106.7% | 13,472,102 | +102.6% | 0.00% | 0.0% |
| Q3 2022 | $33,047,000 | +375.4% | 6,649,331 | +255.9% | 0.00% | – |
| Q2 2022 | $6,951,000 | -81.7% | 1,868,524 | -72.4% | 0.00% | -100.0% |
| Q1 2022 | $37,925,000 | +0.4% | 6,760,306 | +8.8% | 0.00% | 0.0% |
| Q4 2021 | $37,789,000 | -27.0% | 6,215,377 | +16.9% | 0.00% | -33.3% |
| Q3 2021 | $51,795,000 | -13.5% | 5,317,780 | +26.8% | 0.00% | 0.0% |
| Q2 2021 | $59,885,000 | +8.1% | 4,193,620 | +79.8% | 0.00% | 0.0% |
| Q1 2021 | $55,375,000 | – | 2,332,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |